古漢醫藥

000590
7.740.77% ( -0.06 )
延遲 已收盤: 11月16日 15:00:00

股東

全部股東

股東類型

  • 私人企業47.78%
  • 公眾及其他47.62%
  • 機構投資者4.60%
  • 個人與內幕人士<0.01%

主要股東

主要股東 最新
股東
Hunan Sailexian Management Consulting Services Partnership Enterprise (Limited Partnership)
24.47%5,860.70 萬0.00%+0
Hengyang Hongxiang State-owned Investment (holding) Group Co. Ltd
19.11%4,575.73 萬0.00%+030/09/2026
Shanghai Sailexian Enterprise Management Consulting Co., Ltd.
3.16%755.89 萬1.63%+390.34 萬30/09/2026
Morgan Stanley
1.35%322.30 萬0.00%+031/03/2026
Beijing Huaqing Investment Co., Ltd.
1.04%249.45 萬0.40%-95.00 萬30/09/2026
The Goldman Sachs Group, Inc.
0.92%221.35 萬0.00%+031/03/2026
Lion Fund Management Co. Ltd.
0.78%187.89 萬0.25%+61.05 萬30/09/2026
UBS Asset Management AG
0.64%154.04 萬0.00%+031/03/2026
JPMorgan Chase & Co.
0.61%144.89 萬0.00%+031/03/2026
China Southern Asset Management Co., Ltd.
0.20%48.60 萬0.00%+031/12/2025
China Post & Capital Fund Management Co., Ltd.
0.05%11.53 萬--+11.53 萬30/06/2026
Western Leadbank Fund Management Co., Ltd.
0.02%5.35 萬0.00%+031/12/2025
Jpmorgan Asset Management (China) Company Limited
<0.01%1.32 萬0.00%+031/12/2025
Hwabao WP Fund Management Co., Ltd
<0.01%7,600.000.00%+031/12/2025
Truvalue Asset Management Co.,Ltd.
<0.01%7,400.000.00%+031/12/2025
Tibet Eastmoney Fund Management Co.,Ltd.
<0.01%6,400.000.00%+031/12/2025
Chengliang LiuVice President
<0.01%6,400.000.00%+031/12/2025
Xingyin Fund Management Co., Ltd.
<0.01%3,600.000.00%+031/12/2025
Mingya Fund Management Co., Ltd
<0.01%3,200.00--+3,200.0030/06/2026
China Fund Management Co., Ltd.
<0.01%2,500.000.00%+031/12/2025